Flanders Vaccine aims to stimulate innovation in vaccine related research & business as well as to catalyse public-private partnerships

Flanders Vaccine aims to build a reputable ecosystem based on excellence in vaccinology, immunology and immune-oncology, to catalyse public-private partnerships and to stimulate innovation in vaccine-related research & business.

Aims & mission

Flanders Vaccine is a non-profit, strategy-driven platform for academic, industrial and public stakeholders with relevant expertise in human and animal immunotherapeutics and vaccines. 
Flanders Vaccine brings together universities, public and private hospitals, research centres, SMEs, pharma, competence providers, patient organisations, and government bodies to develop novel immunological health solutions and the vaccines of the future.

Flanders Vaccine supports the development of immunotherapeutics and vaccines for both prophylactic and therapeutic targets in humans and animals by facilitating the exchange of know-how and complementary innovative technologies between academia and industry. The Flanders vaccine platform can be seen as an integrated tool that gives rise to more and better partnerships; that prepares us better for future calls for funding; that enables us to network at inspiring meetings and conferences; that generates visibility and attracts significant attention from national and international experts, stakeholders and organisations.

Founding partners

Want to know more about other projects?

Learn more